Vaccine Trials Target Leading Cause of Diarrheal Disease Deaths

Why it matters locally: The District of Columbia, with its diverse population and international connections, could see public health benefits from a successful Shigella vaccine, particularly for vulnerable populations and travelers.

---

Medical researchers are conducting trials for a new vaccine designed to combat Shigella bacteria. Shigella represents a primary cause of diarrheal disease globally. Diarrheal diseases result in over one million deaths each year. Children under the age of five account for nearly half of these fatalities. The development of this vaccine offers a potential intervention against this widespread health issue.